Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act, which has led to investor losses during the class period from March 10, 2021, to April 15, 2025 [3][7]. Allegation Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the DOJ into potential violations of the False Claims Act while discussing such violations in hypothetical terms [3]. - As a result of these omissions, the public statements made by the defendants were materially false and misleading throughout the relevant period [3]. Next Steps for Investors - Investors who purchased or acquired Semler shares and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire for more information regarding their rights and potential claims [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 28th [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across various courts in the United States [5].

Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for alleged violations of securities laws, specifically related to misleading statements made to investors regarding a Department of Justice investigation [1][2]. Company Summary - Semler Scientific, Inc. (NASDAQ: SMLR) is facing a class action lawsuit for making false and misleading statements to the market during the class period from March 10, 2021, to April 15, 2025 [2]. - The lawsuit claims that Semler discussed violations of the False Claims Act in hypothetical terms without disclosing an ongoing DOJ investigation, rendering their public statements materially misleading [2]. Legal Proceedings - Shareholders who purchased shares during the specified class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this is not a requirement for recovery [2][3]. - The deadline for shareholders to register for participation in the lawsuit is October 29, 2025 [2]. Law Firm Overview - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents large hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].

Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for failing to disclose a material investigation by the U.S. Department of Justice regarding potential violations of the False Claims Act [2][3]. Group 1: Allegations and Investigations - Semler Scientific is accused of not disclosing an investigation by the DOJ into possible violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [2]. - The company received an initial civil investigative demand (CID) from the DOJ in July 2017, which investigated whether it violated the False Claims Act by marketing certain tests as reimbursable by Medicare [3]. - On February 11, 2025, Semler Scientific engaged in unsuccessful settlement discussions with the DOJ, raising concerns about a potential lawsuit [3]. Group 2: Financial Impact - Following the revelation of the investigation on February 28, 2025, Semler Scientific's stock price dropped by $4.03, or 9.38%, closing at $38.89 on March 3, 2025 [3]. - After the company announced a settlement agreement with the DOJ for $29.75 million on April 15, 2025, the stock fell by $3.40, or 9.88%, to close at $31.00 on April 16, 2025 [4]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their paperwork by October 28, 2025, to serve as lead plaintiff [5]. - Shareholders do not need to participate in the case to be eligible for recovery, and they can remain absent class members if they choose [5].

Core Points - Semler Scientific, Inc. is currently involved in a pending federal securities class action, with a deadline of October 28, 2025, for investors to seek the role of lead plaintiff [1] Group 1 - The company is reminding investors about the deadline to participate in the class action [1] - Investors who purchased or acquired Semler Scientific securities are encouraged to reach out for more information [1]

NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Semler Scientific, Inc. investors who were adversely affected by alleged securities fraud between March 10, 2021 and April 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.co ...

Accessibility StatementSkip Navigation NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Semler Scientific, Inc. investors who were adversely affected by alleged securities fraud between March 10, 2021 and April 15, 2025. Follow the link below to get more information and be contacted by a ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Semler Scientific securities between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- What’s Happeni ...

Core Insights - Strive's acquisition of Semler Scientific for $1.3 billion represents a significant endorsement of the corporate Bitcoin treasury strategy, valuing Semler at a 210% premium to its previous closing price [1][2] - The acquisition is part of a broader strategy by Strive to accumulate Bitcoin, with plans to purchase an additional 5,816 Bitcoin for $675 million [1][2] Group 1 - The acquisition is seen as a validation of the Bitcoin treasury strategy, indicating a potential shift in corporate America's approach to cryptocurrency [2] - Vivek Ramaswamy, co-founder of Strive and a proponent of cryptocurrency, believes that companies holding Bitcoin will outperform those relying on traditional cash reserves [3] - The timing of the acquisition aligns with a 20.5% surge in Bitcoin's value this year, surpassing the S&P 500's 13.3% gain, aided by favorable regulatory developments [4] Group 2 - Semler Scientific operates a legitimate healthcare business, providing point-of-care tests, which adds a layer of cash flow diversification alongside Bitcoin exposure [4][5] - The combined entity plans to fund future Bitcoin purchases through a "preferred equity only" model, avoiding traditional debt financing methods [5] - Market reactions have been mixed, with Semler shares down over 20% from their recent high, and Strive shares falling 40%, indicating investor uncertainty regarding the aggressive expansion strategy [6]

Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [3][4]. Summary by Sections - **Class Period and Allegations** - The class period for the lawsuit is defined as March 10, 2021, to April 15, 2025 [3]. - Allegations include failure to disclose a material investigation by the U.S. Department of Justice related to the False Claims Act, leading to misleading public statements [3]. - **Next Steps for Shareholders** - Shareholders who purchased SMLR shares during the specified timeframe are encouraged to register for the class action by October 28, 2025 [4]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [4]. - **Law Firm Background** - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified class period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][3]. Group 1: Class Action Details - The class period for the Semler Scientific securities is from March 10, 2021, to April 15, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by October 28, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. - The lawsuit claims that these misstatements led to investor damages when the true details became public [5].